Amplified Attention Training (AAT) for the Treatment of Hemispatial Nelgect

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$1,806,678.00
Award Year:
2013
Program:
SBIR
Phase:
Phase II
Contract:
2R44NS071780-03A1
Award Id:
n/a
Agency Tracking Number:
R44NS071780
Solicitation Year:
2013
Solicitation Topic Code:
NINDS
Solicitation Number:
PAR12-073
Small Business Information
625 Market St., Ste 610, SAN FRANCISCO, CA, 94105-
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
831447730
Principal Investigator:
THOMASVANVLEET
(925) 580-2806
TOMVANVLEET@GMAIL.COM
Business Contact:
THOMASVANVLEET
(925) 580-2806
TOMVANVLEET@GMAIL.COM
Research Institute:
Stub




Abstract
DESCRIPTION (provided by applicant): The goal of the current project is to revise a prototype of a computerized attention training program (Amplified Attention Training, AAT) for hemispatial neglect completed in Phase I, and conduct a multi-site, randomized, controlled trial to establish efficacy in this population. As a group, patients with hemispatial neglect tend to have poorer long-term prognosis and are more likely to require managed care than other patient groups with lesions of comparable size. Our recent studies are among the first to demonstrate that AAT, targeting sustained attention and vigilance deficits, can produce lasting benefits. The overall goal of the current project is to measure 3 co-primary outcomes: attention, executive function and functional capacity. Evidence from our Phase I trial shows that AAT can improve attention and executive function deficits common to hemispatial neglect. At the completion of this project we will have outcomes data sufficient for submission to the FDA for clearance as a medical device indicated for cognitive enhancement in hemispatial neglect (ICD-9 Code 781.8). PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: The goal of this project is to revise a prototype of a computerized cognitive training program (Amplified Attention Training, AAT) for patients with hemispatial neglect completed in Phase I, and conduct a multi-site, randomized controlled trial to demonstrate efficacy. This is important because this large patient population suffers from poor prognosis and a lack of viable treatment options.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government